Checks whether clinics can follow kidney tumor treatment plans for children
Observes how clinics follow treatment steps for children with kidney cancer.
Key facts
- Who runs it
- French Africa Pediatric Oncology Group
- Where
- Dakar, SenegalSee the siteAlso in 5 other countries, 6 sites
- Trial code
- Registry title
- Therapeutic Recommendations for Nephroblastoma
- Status
- Recruiting
- People taking part
- 1,000 people, planned
- Started
- 1 Jul 2020
- Expected to end
- 30 Dec 2030
- Type of study
- Observational
- Treatments tested
- Data collection
- Record updated
- 2 March 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for children with a kidney tumour called nephroblastoma, in one kidney only, who have not had treatment yet and are well enough to be treated.
- Age
- 6 Months to 18 Years
- Sex
- Girls and boys can join.
- Disease stage
- Nephroblastoma (kidney tumour) in one kidney only. The disease must not be too advanced.
- Earlier treatment
- The child must not have been treated before.
Main reasons for not taking part
- Tumour in both kidneys
- Already treated before
- Disease too advanced
- Doubt about the diagnosis
- Treatment refused
The registry criteria, word for word
Show all 2 criteriaShow less
Who can take part
- Unilateral Nephroblastoma Tumor Not previously treated The general health of the child will permit treatment
Who cannot take part
- Bilateral Nephroblastoma tumor Previously treated Disease too advanced Doubt concerning the diagnosis Treatment Refusal
Where in Senegal
Also in 5 other countries, 6 sites
- Hôpital Aristide Le Dantec, Avenue Pasteur, BP 3001Dakar, SenegalContact: DIAGNE AKONDE Fatou-Binetou, DrTaking people
About the trial
What the trial wants to find out
The study is based on results form 2 previous studies carried out by the GFAOP. The aim of this study is to evaluate the capacity of units to follow the recommendations in the protocol.
The group in the trial
- Children with Nephroblastoma
All children coming into the participating units with suspected Nephroblastoma.
Treatment: Data collection
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Therapeutic Recommendations for the Treatment of Children With Nephroblastoma in Africa.
- Plain-language title
- Checks whether clinics can follow kidney tumor treatment plans for childrenGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 2 March 2026